Facts about Zentalis Pharmaceuticals Inc (ZNTL) Stock that you might not know
Wedbush lowered the price target for the Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) stock from “an Outperform” to “a Neutral”. The rating was released on November 08, 2023, according to finviz. The stock was initiated by Wells Fargo, who disclosed in a research note on April 06, 2022, to Overweight and set the price objective to $67. […]
Trading Zentalis Pharmaceuticals Inc (ZNTL) Stock is a good strategy
Wedbush lowered the price target for the Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) stock from “an Outperform” to “a Neutral”. The rating was released on November 08, 2023, according to finviz. The stock was initiated by Wells Fargo, who disclosed in a research note on April 06, 2022, to Overweight and set the price objective to $67. […]
A Tale from the Dusty Corner: Zentalis Pharmaceuticals Inc (ZNTL) Stock
Wedbush lowered the price target for the Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) stock from “an Outperform” to “a Neutral”. The rating was released on November 08, 2023, according to finviz. The stock was initiated by Wells Fargo, who disclosed in a research note on April 06, 2022, to Overweight and set the price objective to $67. […]
A Tale from the Dusty Corner: Zentalis Pharmaceuticals Inc (ZNTL) Stock
Wedbush lowered the price target for the Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) stock from “an Outperform” to “a Neutral”. The rating was released on November 08, 2023, according to finviz. The stock was initiated by Wells Fargo, who disclosed in a research note on April 06, 2022, to Overweight and set the price objective to $67. […]
In the current cycle, Zentalis Pharmaceuticals Inc (ZNTL) Stock is showing signs of growth
Wedbush lowered the price target for the Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) stock from “an Outperform” to “a Neutral”. The rating was released on November 08, 2023, according to finviz. The stock was initiated by Wells Fargo, who disclosed in a research note on April 06, 2022, to Overweight and set the price objective to $67. […]
Is Zentalis Pharmaceuticals Inc (ZNTL) Stock Paving the Way for Earnings?
Wedbush lowered the price target for the Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) stock from “an Outperform” to “a Neutral”. The rating was released on November 08, 2023, according to finviz. The stock was initiated by Wells Fargo, who disclosed in a research note on April 06, 2022, to Overweight and set the price objective to $67. […]
